remember it's 2.3 shares and $75 of mylan. see whether teva raises right before the vote were to come. >> medtronics talking about making more acquisitions. tax domain. >> medtronic went ahead with its inversion. mylan is inverted. perrigo inverted. teva is an israeli company. such important component to strategy when it comes to pharma consolidation. those left out, makes it so much more difficult. >> st. jude med complaining the other day. >> pfizer too. >> big pharma valent. valeant is the story of the year. and actavis. they may be ready to do another deal. >> the ceo of actavis asked about doing a big deal as much as dick costolo is asked whether he is keep his job. >> brent ready to strike saunders. let's get to the bond pits. rick santelli joins us from chicago. >> good morning, david. well interest rates are hopping and the dollar flopping here. look at a two day of 10s. 2.29% is the high yield close of the year going back. these markets lurch on data points. last night some lurches you see in the two-day opened the ch

. >>> increasing so it can legally lyally challengee ye mylan and continued with it's hostile bid. it fell to $60 a share. mylan was off by 1% to 71.6$71.62. >>> china rejected gilliad, the drug has become controversial and cost $1,000 a pill. shares were off $1.41 to $119.80 and post holdings lowered estimates of the impact of the bird flu outbreak on its egg supply. follows a round of testing of its chicken flock. shares were almost 5% higher post day to $52.03. >>> tiger woods has been in the rough and it's been rough. today at the u.s. open he finished 16 over par. this after a shot unheard of 85 two weeks ago leaving many to wonder wheth his professional career is over. so if tiger can't be a winner on the course is his business a loser? to discuss that is dean crutch field, the brand expert with his firm dean crutch field associates. to see you, dean. >> nice to be back. >> i guess that is the question if he's not doing well on t course which he certainly is not doing right now, how is that going to impact his businessw debttriml is it to him? >> it is detrimental to his fran

it was a scene of her and this mylan. it is important for the topic because it really shook the moravian community its core. particularly because moravian leaders among them, on shrunken berger believes that bethlehem which is pictured here in the 18th century and which was their main religious site stop they believe the attack was perpetrated by indians who were loyal to the french and and for someone attempting to be neutral, you can kind of understand this, they will automatically be under suspicion. if you are not for me, you're not declaring that you are with me, that perhaps you are aligned with the enemy. a lot of times in reality, the attempts to remain neutral just didn't work out very well. this is causes a massacre. they are thinking to himself that bethlehem just might be next. what is he to do? he is a leader, this is a town where he has had a lot of refugees have fled the front tier. they come to that let him as a safe haven. they come to bethlehem for safety, what is he supposed to do? there were individual

company when it prevents teva from buying mylan shares.on is can they follow through and have a shot at acquiring mylan. many say it's going to take time they're not willing to wait. >> is there any sense the anger has died down? >> no. >> none. no. >> company's just swinging. >> these things just get nastier and nastier. now teva is coming back. >> can you put that in the context of other battles? >> i don't know there will ever be a letter that we saw from mr. cory the first time to teva. remember that letter? i don't know. that will will stand with corporate letters. we've seen activist write poison things but from the chairman of a board? no expletives. >> still playing in a wit of a classy way. >> that will be the 52-week low. when we start seeing that. >> just write it. >> generally a good tell. you know what's moving? >> the humanas, and cardinal healths. >> cardinal health was up today. a lot of people told me there would be a tieup. >> i told you it was going to be a few weeks. i told you that last monday. >> i'm trying to stick t

in the trouble with mylan a couple of points. one would be simply christian teachings are found in the bible and the words of jesus, for example, you will find things like jesus saying turn the other cheek. pacifists are taking these passages very literally. members of the peace churches have been concerned about issues of loyalty. in their perspective, christians would be loyal to god alone. so, many members of the east churches also had a difficult time ethically swearing and both of allegiance, which was required often for secular rulers. for being treated as citizens, one needed to swear their allegiance. how did this relate with one's loyalty to god stop a lot of times because members of these peace churches, because they emphasize that transcendent loyalty to god, they really desire, they really attempted completely neutral on the civil strife. finally, they have been hesitant to become very and politics. there is involvement in the military efforts within those governments. there is implicit involvement. all of that to say

difference for those types of positions is that guys will be long to be acquired or in other cases, is mylantom: do they take both sides? guest: these days they tend to take one side because of the deal breaks and you are on both sides you get double blasted. tom: is that a hedge fund? guest: that is a hedge fund strategy. hedge funds define a lot of different things. the majority of their hedges are against etf's or indexing. tom: i love what you say. all it is is the application of leverage. guest: it is very target focused. driving the change as an activist or trying to look where consolidation will take place like in the health care industry. brendan: we have been talking about equities, in your notes you have a move into another asset, a much less liquid asset. what is your position? guest: it is one of the few things out there that is extremely rewarding. long story short, these are companies that went bankrupt in 2010. the fcc auctions created tremendous value and if those things trade anywhere near the value of the option there are lots of upsides. brendan: there is no secondary mark

medtronic, mylan left the list because they are no longer u.s. companies.of that. >> good to see you, alan. thanks for the update. >> good to join you. >>> up next on the program, an exclusive interview with gugenheim executive chairman and former bear stearns ceo alan schwartz. his take on the state of the economy, plus the boon in m&a. ah! aflac? aflac! i thought you said this guy was the best? oh, he's a horrible stylist. gah? but he's the best at paying claims fast! really... mmhmm. paid mine in just one day. one day? yea. aaaflaaaac! in just one day, we approve and pay. one day pay, only from aflac. ♪ ♪ (ee-e-e-oh-mum-oh-weh) (hush my darling...) (don't fear my darling...) (the lion sleeps tonight.) (hush my darling...) man snoring (don't fear my darling...) (the lion sleeps tonight.) woman snoring take the roar out of snore. yet another innovation only at a sleep number store. hey, what are you doing? you said you were going to find out about plenti, the new rewards program. i did. in fact, i'm earning plenti points right now. but you're not doing any

. >> now switching focus to health care mylan is telling teva to stop playing games and either make itspproach into a formal offer or walk away. in a letter sent on monday the chairman accuses teva of interfering with the company's effort to buy the smaller rival. shareholders will vote later this year on the proposed $35 billion bid which has been rejected by the drug maker. let's look at price action. trading at 6703 up about . 4%. >> pharma stocks out performed on monday. bristol myers lead the way after a combination of two of its drugs delayed the progression of the skin cancer melanoma. it was up nearly 3% in yesterday's trade. joining us is the fund manager. there's been quite a few test results out in this space recently. who is the main player these days? >> the main players in some of these new drug candidates are bris bristol myers, roche and merck. there's something important happening in cancer therapy right now. it's a stretch to say we've got a cure but we have the potential of taking cancer from a disease that you die from to potentially something you can live with. that

mylan, today it trades at 33. a richer valuation. on that front. tractor supply back in the day it was a 9 p/e company. today it trades at 34 times trailing earnings. monster, this is the best performing stock in the current nasdaq. back then it traded at 10 times earnings. today it trades closer to 60. maybe there are some valuation stretches but if you take a look at the overall market the people that say this time is different, point to what's happening with the large cap stock. s&p 500, going back to 2000 it was trading closer to 30 times earnings. it was trading around 26 times earnings. if you go to today, it's more around 17 or 18. it's maybe a little bit stretched but it's not nearly what it was back during the dot com bubble o.n the one hand you'll find excessive valuations. some people point to private companies or biotech and others say, hey, we're not nearly as close from a large cap perspective. a couple sides to bring a take to the forefront. >> thank you, very much. in the meantime the nasdaq is on pace for its best we

and here i mylan. once judicial activism is another's constitutional constructionism. and part of that conversation with karen. it's only judicial activism when one disagrees with the court's decision, wink-wink. and sea of tranquility says big win for the rich insurance corporation -- zd scotus -- affordable care act enrollees, 748-8003 for you. david on our independent line as we look at the -- outside the supreme court. another decision today. go ahead david. caller: thank you. i think yesterday was a great day. i've had several friends who have been paying $600-$800 a month from insurance costs and their annual expense was a $500 check-up. i mean they're the winners in this case. host: david from washington, d.c. caller: good morning. it's a good day for the united states. this is a case -- the supreme court always has a long-standing rule that it will rule -- with regard to the contempt of the law. so if there's contradiction, the rule with the law's intent and roberts points that out from scalia's own words on the a.c.a. so there's no question about this. this --

reuters is reporting that teva is poised to raise it's stake in mylan. it's positioning itself for a possible legal challenge to the drug maker that rebuffed it's takeover bid. it will be effective on november 1st. they're splitting the computer and printer businesses from the faster growing corporate hardware and services operations. a mixed quarter from guess. earnings beat the street but revenue missed and the current quarter guidance is light. >> we have a couple of other headlines catching our attention this morning. joe mentioned it earlier, jp morgan getting rid of voice mail for half of its 136,000 consumer bank employees. these are people that don't work directly with customers. each line costs about $10 per month and savings of about $16 million a year if the service is eliminated for all the workers. jp morgan isn't the only company recognizing that voice mail is being replaced by text messages and e-mail. you might remember late last year that coca-cola gave employees the options to get rid of voice mail. >> when's the last time you checked y